IL145648A0 - Pharmaceutical composition in unit form containing acetylsalicylic acid and clopidogrel hydrogenosulphate - Google Patents
Pharmaceutical composition in unit form containing acetylsalicylic acid and clopidogrel hydrogenosulphateInfo
- Publication number
- IL145648A0 IL145648A0 IL14564800A IL14564800A IL145648A0 IL 145648 A0 IL145648 A0 IL 145648A0 IL 14564800 A IL14564800 A IL 14564800A IL 14564800 A IL14564800 A IL 14564800A IL 145648 A0 IL145648 A0 IL 145648A0
- Authority
- IL
- Israel
- Prior art keywords
- pharmaceutical composition
- unit form
- acetylsalicylic acid
- form containing
- containing acetylsalicylic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
- A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Hospice & Palliative Care (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Surgery (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Psychiatry (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9905497A FR2792836B3 (fr) | 1999-04-30 | 1999-04-30 | Composition pharmaceutique sous forme unitaire contenant de l'aspirine et de l'hydrogenosulfate de clopidogrel |
PCT/FR2000/001086 WO2000066130A1 (fr) | 1999-04-30 | 2000-04-25 | Composition pharmaceutique sous forme unitaire contenant de l'acide acetylsalicylique et de l'hydrogenosulfate de clopidogrel |
Publications (1)
Publication Number | Publication Date |
---|---|
IL145648A0 true IL145648A0 (en) | 2002-06-30 |
Family
ID=9545071
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14564800A IL145648A0 (en) | 1999-04-30 | 2000-04-25 | Pharmaceutical composition in unit form containing acetylsalicylic acid and clopidogrel hydrogenosulphate |
Country Status (24)
Country | Link |
---|---|
EP (1) | EP1178809A1 (fr) |
JP (1) | JP2002543137A (fr) |
KR (1) | KR20020005735A (fr) |
CN (1) | CN1359294A (fr) |
AR (1) | AR023789A1 (fr) |
AU (1) | AU4303600A (fr) |
BR (1) | BR0010194A (fr) |
CA (1) | CA2371231A1 (fr) |
CZ (1) | CZ20013887A3 (fr) |
EA (1) | EA200100959A1 (fr) |
EE (1) | EE200100559A (fr) |
FR (1) | FR2792836B3 (fr) |
HK (1) | HK1041823A1 (fr) |
HU (1) | HUP0202329A2 (fr) |
IL (1) | IL145648A0 (fr) |
IS (1) | IS6084A (fr) |
MX (1) | MXPA01011071A (fr) |
NO (1) | NO20015295L (fr) |
NZ (1) | NZ514248A (fr) |
PL (1) | PL351923A1 (fr) |
SK (1) | SK15542001A3 (fr) |
TR (1) | TR200103039T2 (fr) |
UY (1) | UY26131A1 (fr) |
WO (1) | WO2000066130A1 (fr) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL206138B1 (pl) | 2000-12-25 | 2010-07-30 | Daiichi Sankyo Company Limiteddaiichi Sankyo Company Limited | Kompozycja farmaceutyczna zawierająca aspirynę oraz zestaw i zastosowanie składników kompozycji |
US6767913B2 (en) | 2001-12-18 | 2004-07-27 | Teva Pharmaceutical Industries Ltd. | Crystal forms iii, iv, v, and novel amorphous form of clopidogrel hydrogensulfate, processes for their preparation, processes for the preparation of form i, compositions containing the new forms and methods of administering the new forms |
US7074928B2 (en) | 2002-01-11 | 2006-07-11 | Teva Pharmaceutical Industries, Ltd. | Polymorphs of clopidogrel hydrogensulfate |
US6800759B2 (en) | 2002-08-02 | 2004-10-05 | Teva Pharmaceutical Industries Ltd. | Racemization and enantiomer separation of clopidogrel |
IL166593A0 (en) | 2002-08-02 | 2006-01-15 | Racemization and enantiomer separation of clopidogrel | |
JP4917255B2 (ja) * | 2003-10-16 | 2012-04-18 | 第一三共ヘルスケア株式会社 | サリチル酸類含有経口組成物 |
WO2005070464A2 (fr) * | 2004-01-21 | 2005-08-04 | Biofarma Ilac Sanayi Ve Ticaret A.S. | Formulation de comprimes de bisulfate de clopidogrel |
WO2006138214A1 (fr) * | 2005-06-13 | 2006-12-28 | Elan Pharma International, Limited | Preparations combinant de l'aspirine et des nanoparticules de clopidogrel |
KR20070009851A (ko) * | 2005-07-14 | 2007-01-19 | 씨제이 주식회사 | 클로피도그렐 황산수소염 함유 약학 조성물 |
CN101253179B (zh) * | 2005-09-21 | 2010-12-29 | 株式会社钟根堂 | S-氯吡格雷的树脂酸盐复合物及其制备方法 |
KR20070044323A (ko) * | 2005-10-24 | 2007-04-27 | 에스케이케미칼주식회사 | 보관안정성이 개선된 클로피도그렐 황산수소염 함유 경구용제제 |
EP2001449A2 (fr) * | 2006-04-05 | 2008-12-17 | Cadila Healthcare Ltd. | Formulation de clopidogrel à libération modifiée |
EP1900358A1 (fr) * | 2006-09-16 | 2008-03-19 | Cimex Pharma AG | Formulations pharmaceutiques contenant du clopidogrel |
HUP0600839A3 (en) * | 2006-11-14 | 2008-09-29 | Egis Gyogyszergyar Nyrt | Solid pharmaceutical composition containing polymorph i of clopidogrel hydrogensulfate and process for the preparation thereof |
CN101951896B (zh) * | 2008-02-22 | 2012-11-28 | 韩兀生物制药株式会社 | 复合制剂 |
CN101695496A (zh) * | 2009-10-15 | 2010-04-21 | 苏春华 | 一种含有三氟柳和氯吡格雷的药物组合物 |
JP2013032289A (ja) * | 2009-10-28 | 2013-02-14 | Daiichi Sankyo Co Ltd | ワックス安定製剤 |
RU2484820C2 (ru) * | 2011-02-24 | 2013-06-20 | Общество с ограниченной ответственностью "Озон" | Комбинированное лекарственное средство, являющееся ингибитором агрегации тромбоцитов |
KR101675501B1 (ko) | 2011-11-02 | 2016-11-14 | 한국유나이티드제약 주식회사 | 클로피도그렐 및 아스피린의 복합제제 |
CN102406938A (zh) * | 2011-11-29 | 2012-04-11 | 北京阜康仁生物制药科技有限公司 | 一种抗血栓的药物组合物 |
JP6004524B2 (ja) * | 2012-07-11 | 2016-10-12 | 大原薬品工業株式会社 | クロピドグレル硫酸塩含有錠剤の製造方法 |
WO2015015062A1 (fr) * | 2013-08-02 | 2015-02-05 | Sanofi | Comprime pharmaceutique comprenant de l'acide acetylsalicylique et du clopidogrel |
CN104434932B (zh) * | 2014-12-18 | 2017-05-24 | 成都苑东生物制药股份有限公司 | 一种硫酸氢氯吡格雷阿司匹林片药物组合物及其制备方法 |
WO2017037741A1 (fr) * | 2015-09-02 | 2017-03-09 | Sun Pharmaceutical Industries Ltd | Forme posologique solide et compacte à base d'aspirine et de clopidogrel |
CN115737578A (zh) * | 2022-11-23 | 2023-03-07 | 石家庄四药有限公司 | 一种硫酸氢氯吡格雷阿司匹林复方片及其制备方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2623810B2 (fr) | 1987-02-17 | 1992-01-24 | Sanofi Sa | Sels de l'alpha-(tetrahydro-4,5,6,7 thieno(3,2-c) pyridyl-5) (chloro-2 phenyl) -acetate de methyle dextrogyre et compositions pharmaceutiques en contenant |
US5576328A (en) * | 1994-01-31 | 1996-11-19 | Elf Sanofi | Method for the secondary prevention of ischemic events |
FR2744918B1 (fr) | 1996-02-19 | 1998-05-07 | Sanofi Sa | Nouvelles associations de principes actifs contenant un derive de thieno(3,2-c)pyridine et un antithrombotique |
FR2779726B1 (fr) | 1998-06-15 | 2001-05-18 | Sanofi Sa | Forme polymorphe de l'hydrogenosulfate de clopidogrel |
-
1999
- 1999-04-30 FR FR9905497A patent/FR2792836B3/fr not_active Expired - Fee Related
-
2000
- 2000-04-25 JP JP2000615014A patent/JP2002543137A/ja not_active Withdrawn
- 2000-04-25 HU HU0202329A patent/HUP0202329A2/hu unknown
- 2000-04-25 TR TR2001/03039T patent/TR200103039T2/xx unknown
- 2000-04-25 CZ CZ20013887A patent/CZ20013887A3/cs unknown
- 2000-04-25 EP EP00922737A patent/EP1178809A1/fr not_active Withdrawn
- 2000-04-25 AU AU43036/00A patent/AU4303600A/en not_active Abandoned
- 2000-04-25 EA EA200100959A patent/EA200100959A1/ru unknown
- 2000-04-25 PL PL00351923A patent/PL351923A1/xx not_active Application Discontinuation
- 2000-04-25 CA CA002371231A patent/CA2371231A1/fr not_active Abandoned
- 2000-04-25 IL IL14564800A patent/IL145648A0/xx unknown
- 2000-04-25 CN CN00807001A patent/CN1359294A/zh active Pending
- 2000-04-25 NZ NZ514248A patent/NZ514248A/xx unknown
- 2000-04-25 SK SK1554-2001A patent/SK15542001A3/sk unknown
- 2000-04-25 EE EEP200100559A patent/EE200100559A/xx unknown
- 2000-04-25 WO PCT/FR2000/001086 patent/WO2000066130A1/fr not_active Application Discontinuation
- 2000-04-25 BR BR0010194-0A patent/BR0010194A/pt not_active Application Discontinuation
- 2000-04-25 MX MXPA01011071A patent/MXPA01011071A/es unknown
- 2000-04-25 KR KR1020017013830A patent/KR20020005735A/ko not_active Application Discontinuation
- 2000-04-28 UY UY26131A patent/UY26131A1/es not_active Application Discontinuation
- 2000-04-28 AR ARP000102020A patent/AR023789A1/es unknown
-
2001
- 2001-09-25 IS IS6084A patent/IS6084A/is unknown
- 2001-10-29 NO NO20015295A patent/NO20015295L/no not_active Application Discontinuation
-
2002
- 2002-05-14 HK HK02103639.9A patent/HK1041823A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
BR0010194A (pt) | 2002-02-13 |
EP1178809A1 (fr) | 2002-02-13 |
WO2000066130A1 (fr) | 2000-11-09 |
PL351923A1 (en) | 2003-06-30 |
CZ20013887A3 (cs) | 2002-02-13 |
SK15542001A3 (sk) | 2002-02-05 |
KR20020005735A (ko) | 2002-01-17 |
NZ514248A (en) | 2003-06-30 |
FR2792836B3 (fr) | 2001-07-27 |
UY26131A1 (es) | 2000-12-29 |
CN1359294A (zh) | 2002-07-17 |
AU4303600A (en) | 2000-11-17 |
MXPA01011071A (es) | 2002-07-22 |
CA2371231A1 (fr) | 2000-11-09 |
JP2002543137A (ja) | 2002-12-17 |
AR023789A1 (es) | 2002-09-04 |
EE200100559A (et) | 2003-02-17 |
TR200103039T2 (tr) | 2002-01-21 |
IS6084A (is) | 2001-09-25 |
HK1041823A1 (zh) | 2002-07-26 |
FR2792836A1 (fr) | 2000-11-03 |
EA200100959A1 (ru) | 2002-06-27 |
NO20015295D0 (no) | 2001-10-29 |
HUP0202329A2 (en) | 2002-10-28 |
NO20015295L (no) | 2001-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL145648A0 (en) | Pharmaceutical composition in unit form containing acetylsalicylic acid and clopidogrel hydrogenosulphate | |
HUP0302550A3 (en) | Glucopyranosyloxypyrazole derivatives and use thereof in medicines and pharmaceutical compositions containing them | |
HUP0203588A3 (en) | Analgesic pharmaceutical compositions and their use | |
HUP0203895A3 (en) | Substituted azaindoles and pharmaceutical compositions containing them and their use | |
HUP0200548A2 (hu) | Gyógyszerészeti készítmények és alkalmazásuk | |
HUP0202338A3 (en) | Pharmaceutical composition containing fenofibrate and preparation method | |
HUP0203939A3 (en) | Pharmaceutical compounds and compositions containing them and their use | |
HUP0203575A3 (en) | Pharmaceutical compositions containing th2 differentiation inhibitors and their use | |
HUP0203556A3 (en) | Pharmaceutical compositions containing oxcarbazepine and their use | |
HUP0203971A3 (en) | Imidazoimidazoles and triazoles as anti-inflammatory agents and pharmaceutical compositions containing them and their use | |
HUP0200831A2 (en) | Novel pharmaceutical composition containing amoxycillin and its use | |
HUP0203028A3 (en) | Pharmaceutical formulation containing tolterodine and its use | |
HUP0301042A3 (en) | Pharmaceutical composition useful in contraception | |
PL354315A1 (en) | Cosmetic or pharmaceutical composition in solid form comprising bis-acyl-amides | |
HUP0300318A3 (en) | Pyrazolobenzodiazepines as cdk2 inhibitors and pharmaceutical compositions containing them and their use | |
IL150383A0 (en) | Glyburide and pharmaceutical compositions containing the same | |
HUP9901221A3 (en) | Substituted tricyclic compounds and their use in pharmaceutical compositions | |
HUP0200055A3 (en) | 16-hydroxyestrienes and pharmaceutical compositions containing the same | |
HUP0203121A3 (en) | Pharmaceutical composition containing substituted benzimidazoles and its use | |
HU9901219D0 (en) | Substituted tricyclic compounds and their use in pharmaceutical compositions | |
GB9918885D0 (en) | Pharmaceutical formulations in hydroxypropymethycellulose capsules | |
HUP0101733A3 (en) | Pharmaceutical compositions containing sulfonyl-dipeptides and their use | |
HUP0203383A3 (en) | Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof | |
HUP0201443A3 (en) | 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives and pharmaceutical compositions containing them | |
HUP0500956A3 (en) | Oxapenem-3-carboxylic acids and pharmaceutical compositions containing them |